Chief financial officer

Fuller, Smith & Turner PLC: Directorate

Retrieved on: 
Monday, September 27, 2021
Fuller, Smith & Turner, Neil Adams (judoka), M25, Jurassic Coast, Tropical and subtropical dry broadleaf forests, Home counties, Chief financial officer, Bel, Board, Dragon, New Forest

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • Fuller, Smith & Turner PLC, the premium pubs and hotels business, today announces that, subsequent to our announcements on 26 February 2021 and 11 June 2021, Adam Councell will step down from his role of Finance Director, and from the Board, on 30 September 2021.
  • As previously announced, we are delighted to have secured a highly experienced successor to Adam in Neil Smith.
  • For further information please contact:
    Fuller, Smith & Turner PLC is the premium pubs and hotels business that is famous for beautiful and inviting pubs with delicious fresh food, a vibrant and interesting range of drinks, and engaging service from passionate people.

Sosei Heptares Operational Highlights and Consolidated Results for the Second Quarter and First Half 2021

Retrieved on: 
Thursday, August 12, 2021
Marginal cost, AbbVie, Lists of diseases, Inflammation, Neurology, Novartis, Immunology, Q&A, Mina, JPY, Investment, BST, Gastroenterology, Intention, JST, AstraZeneca, Star, RSU, TSE, Agonist, Invention, Research, G&A, Tokyo Stock Exchange, CEO, Achievement, MC4, Degenerative disease, Public, Company, Asset, Failure, International, Nasdaq, G protein-coupled receptor, Lilly, Restricted stock, National Insurance, Acquisition, Pain, CGRP, Therapy, The Company, Schizophrenia, Group, Chief financial officer, GPCR, Pfizer, Technology, GBP, Pharmaceutical industry, Bank, Fine chemical

TOKYO and CAMBRIDGE, England, Aug. 12, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2021.

Key Points: 
  • TOKYO and CAMBRIDGE, England, Aug. 12, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2021.
  • Shinichi Tamura, Chairman, President and CEO of Sosei Heptares, commented:"We are pleased with the progress we have made during 2021.
  • "Sosei Heptares" is the corporate brand and trademark of Sosei Group Corporation, which is listed on the Tokyo Stock Exchange (ticker: 4565).
  • Sosei, Heptares, the logo and StaR are trademarks of Sosei Group companies.

Sosei Heptares Operational Highlights and Consolidated Results for the Second Quarter and First Half 2021

Retrieved on: 
Thursday, August 12, 2021
Marginal cost, AbbVie, Lists of diseases, Inflammation, Neurology, Novartis, Immunology, Q&A, Mina, JPY, Investment, BST, Gastroenterology, Intention, JST, AstraZeneca, Star, RSU, TSE, Agonist, Invention, Research, G&A, Tokyo Stock Exchange, CEO, Achievement, MC4, Degenerative disease, Public, Company, Asset, Failure, International, Nasdaq, G protein-coupled receptor, Lilly, Restricted stock, National Insurance, Acquisition, Pain, CGRP, Therapy, The Company, Schizophrenia, Group, Chief financial officer, GPCR, Pfizer, Technology, GBP, Pharmaceutical industry, Bank, Fine chemical

TOKYO and CAMBRIDGE, England, Aug. 12, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2021.

Key Points: 
  • TOKYO and CAMBRIDGE, England, Aug. 12, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2021.
  • Shinichi Tamura, Chairman, President and CEO of Sosei Heptares, commented:"We are pleased with the progress we have made during 2021.
  • "Sosei Heptares" is the corporate brand and trademark of Sosei Group Corporation, which is listed on the Tokyo Stock Exchange (ticker: 4565).
  • Sosei, Heptares, the logo and StaR are trademarks of Sosei Group companies.

DXP Enterprises Provides Update on Q2 Performance and Sets New Date for Earnings Release

Retrieved on: 
Thursday, August 5, 2021
Oil, Gas, Chemicals, Plastics, Retail, Commercial Building & Real Estate, Construction & Property, Energy, Manufacturing, Other Transport, Mining, Minerals, Forest Products, Agriculture, Natural Resources, Transport, Logistics, Supply Chain Management, Food, Beverage, Yee, Company, Investment, Solution, U.S. Securities and Exchange Commission, Maintenance, Private Securities Litigation Reform Act, Security (finance), Review, Health, Growth, Analysis, Form, COVID-19, Financial condition report, Shared services center, SEC, DXP, Terminology, Form 10-K, Result, Chief financial officer, GAAP, Bank, Risk management

DXP is currently in its quiet period ahead of its second quarter 2021 earnings call and will not host a call to provide additional commentary regarding this preannouncement.

Key Points: 
  • DXP is currently in its quiet period ahead of its second quarter 2021 earnings call and will not host a call to provide additional commentary regarding this preannouncement.
  • DXP Enterprises, Inc. is a leading products and service distributor that adds value and total cost savings solutions to industrial customers throughout the United States, Canada and Dubai.
  • DXP's breadth of MROP products and service solutions allows DXP to be flexible and customer-driven, creating competitive advantages for our customers.
  • The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

iRhythm Technologies Announces Second Quarter 2021 Financial Results

Retrieved on: 
Thursday, August 5, 2021
IRTC, Efficiency, U.S. Securities and Exchange Commission, Arrhythmia, Technology, Novita (company), Macs, Private Securities Litigation Reform Act, Securities Act of 1933, Growth, Patient, Securities Exchange Act of 1934, News, SAN, Investment, Medicare, Chief financial officer, Compensation, Nasdaq, Federal Food, Drug, and Cosmetic Act, GLOBE, Pharmaceutical industry

SAN FRANCISCO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2021.

Key Points: 
  • SAN FRANCISCO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2021.
  • Cash and Short-Term Investments were $255.7 million as of June 30, 2021, a $6.6 million decrease from March 31, 2021
    Our second quarter results reflected continued strong demand for our Zio platform, as well as solid execution on our operating goals.
  • We also made significant advancements to our technology platform in the second quarter with two new 510k clearances that demonstrate our continued commitment to innovation.
  • Operating expenses for the second quarter of 2021 were $72.3 million, compared to $55.6 million for the same period in 2020.

AAON Reports Record Sales for the Second Quarter of 2021 and a Robust Increase in Backlog

Retrieved on: 
Thursday, August 5, 2021
Company, Chief executive officer, Public expenditure, Eastern Time Zone, Private Securities Litigation Reform Act, Eastern, Heating, ventilation, and air conditioning, Engineering, Growth, EPS, Sale, Heat, AAON, Capital, Marketing, Air conditioning, Chief financial officer, Capital expenditure, Renewable energy, Video game, Bank

The year over year increase in net sales was driven by robust replacement demand broadly across the nonresidential building market that increased our volume 24.6%.

Key Points: 
  • The year over year increase in net sales was driven by robust replacement demand broadly across the nonresidential building market that increased our volume 24.6%.
  • The sequential improvement in backlog reflects the improved demand that we experienced throughout the second quarter.
  • Our sales in the second quarter of 2020 were up year over year 5% versus the commercial market being down approximately 20%-25%.
  • The Company will host a conference call on August 6, 2021 at 9:00 A.M. (Eastern Time) to discuss the second quarter 2021 results.

Quanterix Corporation Releases Operating Results for Second Quarter of 2021

Retrieved on: 
Thursday, August 5, 2021
Science, Cardiology, Other Science, Biotechnology, Pharmaceutical, Oncology, Health, Infectious Diseases, AFL, Plasma, Corporation, Neurodegeneration, Webcast, Policy, Blood, Neuro, Biomarker, Industry, Diagnosis, Science, Publication, Lists of diseases, Goldman, Nature Communications, Food and Drug Administration, ID, Drug development, Biotechnology, Chief financial officer, Conference, GAAP, Nasdaq, PerkinElmer, Cryptocurrency, Medical imaging, Mobile phone, Pharmaceutical industry, Management

Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the three months ending June 30, 2021.

Key Points: 
  • Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced financial results for the three months ending June 30, 2021.
  • Record Product Revenue of $18.7M for Q2 2021, an increase of 175% versus prior year Q2.
  • Quanterix Simoa technology was highlighted in 130 new publications, bringing total Simoa-specific inclusions to more than 1,300 publications.
  • In conjunction with this announcement, Quanterix Corporation will host a conference call on August 5 at 4:30pm EDT.

Outset Medical Names Nabeel Ahmed as Chief Financial Officer

Retrieved on: 
Thursday, August 5, 2021
Data Management, Medical Devices, Health, Technology, Hospitals, Mobile, Wireless, EBay, Water purification, Commerce, Medicine, Violent Crime Reduction Act 2006, Master of Business Administration, 8x8, Technology, University, Dialysis, Controller, Growth, Patient, Wharton School of the University of Pennsylvania, University of Pennsylvania, View, Accounting, Food and Drug Administration, Tresco Heliport, Ernst, New York Stock Exchange, Interim, Ernst & Young, Outset Media, Chief financial officer, Nasdaq, Management

Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Nabeel Ahmed, currently serving as Outsets Interim Chief Financial Officer, has transitioned to the permanent role of Chief Financial Officer, effective immediately.

Key Points: 
  • Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Nabeel Ahmed, currently serving as Outsets Interim Chief Financial Officer, has transitioned to the permanent role of Chief Financial Officer, effective immediately.
  • Nabeels extensive experience across a variety of finance roles and his tenure as a leader at Outset give me great confidence in his ability to lead as Chief Financial Officer, said Leslie Trigg, President and Chief Executive Officer.
  • I am thrilled to step into this role at such an exciting time for Outset, said Nabeel Ahmed, Chief Financial Officer.
  • Nabeel joined Outset in May 2020 as the companys Vice President, Controller and has served as Interim Chief Financial Officer since July 16, 2021.

The Estée Lauder Companies to Webcast Discussion of Fiscal 2021 Fourth Quarter and Full Year Results on August 19, 2021

Retrieved on: 
Thursday, August 5, 2021
Cosmetics, Retail, Luxury, Consumer, Women, Teens, Men, Company, Chief executive officer, Webcast, El, Aveda, EVP, Origin, NIOD Institute for War, Holocaust and Genocide Studies, DKNY, New York Stock Exchange, Skin care, Le Labo, Chief financial officer, Trex Company, Inc.

The Este Lauder Companies Inc. (NYSE: EL) will release fiscal 2021 fourth quarter and full year results on August 19, 2021.

Key Points: 
  • The Este Lauder Companies Inc. (NYSE: EL) will release fiscal 2021 fourth quarter and full year results on August 19, 2021.
  • On that date, at 9:30 a.m. (ET), the Company will provide a live webcast of its conference call discussing the results, future prospects and recent corporate developments.
  • Fabrizio Freda, President and CEO, and Tracey T. Travis, EVP and CFO, will host the call.
  • The Este Lauder Companies Inc. is one of the worlds leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products.

Globant to Announce Second Quarter 2021 Financial Results on August 12th

Retrieved on: 
Thursday, August 5, 2021
Chief executive officer, Rockwell Automation, Harvard University, Organization, Massachusetts Institute of Technology, IDC, Globant, New York Stock Exchange, Santander, Chief financial officer, Stanford University, Electronic Arts, Google

LUXEMBOURG, Aug. 5, 2021 /PRNewswire/ --Globant (NYSE: GLOB), a digitally native technology services company, today announced it will release results for the second quarter ended June 30th, 2021 on Thursday August 12th, 2021 after the close of regular market hours.

Key Points: 
  • LUXEMBOURG, Aug. 5, 2021 /PRNewswire/ --Globant (NYSE: GLOB), a digitally native technology services company, today announced it will release results for the second quarter ended June 30th, 2021 on Thursday August 12th, 2021 after the close of regular market hours.
  • Following the release, Martin Migoya, Globant's CEO & co-founder, and Juan Urthiague, Globant's CFO, will discuss the results in a video conference call beginning at 4:30pm ET.
  • Video conference call access information is:
    We are a digitally native company that helps organizations reinvent themselves to create a way forward and unleash their potential.
  • We were named a Worldwide Leader in CX Improvement Services by IDC MarketScape report.